Unaudited Standalone Financial Results of the Company for the quarter and half year ended on 30th September, 2026.

AD LINE CHEM ~AB L·M:TED 05th November, 2026 Department of Corporate Services BSE Limited P. J. Towers, Dalal Street, Fort, Mumbai -400 001 Scrip Code: 524604 Dear Sir /Madam, Sub.: Outcome of the meeting of the Board of Directors pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to the provisions of Regulation 30 read with Part A of Schedule III and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its meeting held today, i.e., Thursday, 05th November, 2026, has inter alia, considered, approved, and taken on record the following items of business: 1. Standalone Unaudited Financial Results: The Board considered and formally approved the Standalone Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026, prepared in accordance with the applicable Indian Accounting Standards (Ind AS). 2. Limited Review Report: The Board considered and adopted the Limited Review Report submitted by the Statutory Auditors of the Company on the aforesaid Standalone Unaudited Financial Results for the quarter and half year ended September 30, 2026. We hereby declare and confirm that the Statutory Auditors of the Company have issued the said Limited Review Report with an unmodified opinion. Please note that the meeting of the Board of Directors commenced at 05:10 P.M. and concluded at 05:40 P.M. The approved Standalone Unaudited Financial Results along with the Limited Review Report are enclosed herewith for your reference and records. Kindly take on your record the aforesaid information and acknowledge the same. Thanking you, Yours faithfully, For, Adline Chem Lab Limited Vrushank Balkrushna Patel Managing Director DIN:05310613 CIN: L35106GJ1988PLC010956 AD LINE CHEM LAB LIMITED (Formerly Kamron Laboratories Limited) Registered Address: -A-514, Stellar, Opp. Arista Building, Sindhu ~.h.sl~ Road, Bodakdev, Ahmedabad -380054, Gujarat, India Phone: -99799 41234 I Email: -secretarial.adlinechemlab@gmaif.com I Website: www.adlinechem.com ADLINE CHEM LAB LIMITED 4-514, Stellar, Opts, Arista Bosi0diIso SIIIdIIa Bhavao Road, Bodakdev, Ahmedabad - 3000254. ooJurat. India CIN L35006011980PLC010956 Ph.no.: 99799 41234 Email Id, seorelarloLadlliteohemlab@gmaiLcom Webolte wmso,odliolsom)ab.rom STANDALONE UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30th September, 2026 (to to l.al,So} Quarter Ended Roll Your Ended Year Ended aIasu 30th Sep 2026 311115 (one 2026 30th Sop 2025 lolinSep 2026 3tlh Sep 2ol2s 31st Mar 2026 Uoassdflrd ooaodileot Uouodllod Unaudited Unaudited lodiled Revenue from oporuU001 - - - - - Othorlorome - 01.99 - 11.99 1.15 TOUt 1500100 11.99 - 11.99 LII Esprocos Cool olonaienais 000tosoed - - - - - Purchase of Stock In Trade - - - - Cfraogeo in lnvennorioo of floished good.,, Stock-in -Trudy - - . - - and work-in-progress Emp(oyenhenefiln ropenon 0.75 0.75 0.18 2.50 0.99 2.06 Finance roots 4.66 4,04 2.07 9,49 5.65 17.67 Depreciation and am00010aloon expense . - Othrretpeooeo 2.46 3.21 4.97 5.67 7.26 13.08 70101 rupoosos 7.07 080 8.02 16.67 1389 32.05 Prolil/(Ioeo) before eseeptional Inc.. ..it has (7.07) 3.20 (802) (4.67) (13.09) (31.70) Eorrptlooal 00.5.5 . . . Peofll/(lool( before tax (7.07) 3.20 (8.02) (4.67) (13.89) (31.70) The eopo000t 0,00 0.51 (0.78) 0.07 (1.50) 3.59 Prior ponool 000 . 0.01 . . . 199 Onlerord tao 0.80 - (0.76) 0.07 (LSO( Profit( Loss) for the period from 008fi80log operations (0.7S) 4.01 (726) (4.75) (12.39) (2011) erofls/olose) from diss00600td oporotloos 'las eepennr of disoontinuril rperati000 . - Pr000/(foss) from Discontinued operations (after lao) . . . Prtsftt/000eo) for 160 period (0.75) 4.01 (7.26) (4.05) (12.39) (2811) Other Comprehensive become . - 0,15 . 8.30 - lOroro that soil) 000 be rerlassiled on profit or lots( Ben off . . 0.15 . 0.50 InceSt due to actuarial valuation o(gra1001y . . 0,20 . 0,40 Deferred tao . ' (0.051 . (0.10) ltrmo that mill be, oclaIisified to profit or lost (Net of tat) . Total Comprehensive 11500100 for the period (875) 4.00 (7,11) (4.75) (12,09) (2011) raid-up equity nharr vepioul (Parr Valor of tOo Shator Ito. 101.00 005.00 105.00 580.00 905.00 100.00 10/-roth) sarollsgo p .. quity sham (for 0008noIsgoporatloo(, Bohr . (0.15) 0.07 (0.12) (0.00) (0.20) (0.40) Diluted (0.19) 0.07 (0,12) (0.00) 10,20) (0.40) tarstietgs per 091519, oham (for d0s0005soed opera0os(t Basic (0.11) 0.07 (0,12) (0.00) (0.212 (0.40) liluo,'d (0.15) 0.07 (0.02) (0.00) (0,20) (0.40( Earnings per equity share ((or continuing & dtonostislsed ope001iots(, flooR (0.15) 0.07 (0.02) 10.80) (0,21) (0.40( Piloted falst 01,07 (0.12) (0.08) 10.2111 (0.40) fistos 1, This 10310m000 han been prepared in ovroedanor with the lndiao 010000000 Stund00000 (Ird AS) 05 preorflhed coder fovl000 133 of Ifor Companies Act 2003 4u000nlng Standards Robe. 2005 (as amooded). The otatoloey asditoet of tb0 company have carried out 1imi1ed roniem of the 0naoriat results for the quarter coded September 30.2026, 2.Th esr rruultx have been oeoirwrd and rer000mnoded for adoption by the Audi, Commioecin its meosiog held on N000mber 05, 2026, and approved by the Board of Diroroors at its meofing held en November 05, 2075, The Statutory 804ltoro Rop000 4001 not bavo any qaalboralluv I modlooa000, 3.lI ner 00466 1100, 'opreotlogSrgoornt' is not win) lrublo to ll0000mpaoy, 060 company has not dlsriosed any segment iofonenoOloo. 4.BP S is n000n000llaed for the quornec coded Sepeetoher 30. 2026,( 000 30. 2026 ..it SopOrooboc 30, 2025 and for the half yew ended September 36,2026 and September 30. 2025. 0. OUter eoprooro inriudex 0.. 0.06 Lakho penalty by ISO for 000-appoi0000oo of a Company Srrmtooy (OS) for the 50805cr ended (ooe-2020. 6. Other Inc.- avo05010g 100.0.01.99 lab), reported for the qourter, ended 30 June 2026 Is atteobaOahlo in the osoudl8u5oo of boernmfngs pars000000 loads adjustn000Lo. Flare, Ahmedabad Foe-, ADLINE CII0.AB LIMITED Date, 05/11/2026 NIL VRDSHANI( BALKOESHNA PATES MANAGING DIRECTOR 0INt05310613 STANDALONE AUDITED STATEMENT OF ASSETS & LIABILITIES AS AT September 30th ,2026 (Rs in Lakhs) As at 30th As at 31stMarch P5rtl)IaFS September2026 2026 ASSETS Current assets (a) Financial Assets (I) Cash and cash equivalents 7.47 6.55 (b) Other current assets 3.84 0.37 TOTAL ASSETS 11.31 6.91 EQUITY AND LIABILITIES Equity (a) Equity Share capital 585.00 585.00 (b) Other Equity (767.19) (762.44) Non-current liabilities - - (a) Financial Liabilities - - (i) Borrowings 189.49 180.27 (b) Provisions (c) Deferred tax liabilities (Net) 2.41 2.34 Current liabilities (a) Financial Liabilities (i) Borrowings (Ia) Lease Liability (ii) Trade payables (iii) Other financial liabilities [other than those specified in item (c)] 0.47 1.01 (b) Other current liabilities 1.14 0.73 TOTAL EQUITY AND LIABILITIES 11.31 6.91 Place: Ahmedabad For, ADLINE CHEMLAB IMITED Date: OS/11/2026 MR. VRUSHANK BALKRUSHNA PATEL MANAGING DIRECTOR DIN:05310613 ADLINE CHEMLAB LIMITED Standalone statement of Cash flow for the Half Year ended September 30th,2026 (Rs in LakEs) For the Half Year For the Half Year Particulars ended September ended March 30,2026 31,2026 A Cash flow from Operating Activities Net Profit Before Tax (4.67) (31.70) Adjustments for: Add Interest Expense 565 11.33 Add Iritrest Income - Add Provision for Gratuity - 0.53 Add Changes due to Modification in Financial Liabilities - 3.55 Less Gratuity written back - (1.15) Operating Profit I (Loss) before Working Capital Changes 0.97 (17.44) Adjustments for: Increase/(Decrease) in Other Current Liabilities (0.14) 0.73 Increase/(Decrease) in Provisions - 0.00 (Increase)/Decrease in inventories - - (Increase)/Decrease in other current assets (3.48) 0.86 Cashflow generated from Operating Activities (2.64) (15.83) Income Tax Paid / Income Tax Refund (Net) - - Net Cashflow generat [Showing first 8,000 characters — download PDF for full document]